ACL vs MYX

ASX Healthcare sector comparison — updated 23 Jul 2026 — Healthcare sector

ACL

AUCLINICAL FPO [ACL]

51MEDIUM

MYX

M PHARMA FPO [MYX]

51MEDIUM

Score Breakdown

ACL MYX
Technical
51
53
Catalyst
71
50
Sentiment
50
50
Fundamental
68
85
Momentum
52
38
Risk Gate
36
42

Key Metrics

ACL Metric MYX
$433.7MMarket Cap$225.9M
575KAvg Volume (20d)212K
+6.5%Short Interest+2.4%
$2.97052-Week High$6.500
$1.83352-Week Low$2.040
+0.0%Daily Change+0.7%
$2.330Reference Price$2.770
+16.7%ROE-20.6%
+3.6%Profit Margin-20.4%

Active Signals

ACL Signals

●Trading above both moving averages — the trend is your friend here
●Drifting lower — down 3.3% over the last 5 days
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (0.6x)
●EPS estimates revised upward (+10pts)
●Post-earnings drift: negative surprise (SUE -10)
●New substantial holder(s) (1)

MYX Signals

●MACD momentum is losing steam
●Stochastic is deep in oversold territory — bounce conditions forming
●Drifting lower — down 5.1% over the last 5 days
●Beating the Small Ords index — relative strength of 1.21, so it's outpacing the pack
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (0.6x)

Ask Scout AI to compare ACL and MYX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

IPD vs NXN →CBL vs NXN →ACL vs NXN →NTI vs NUZ →NTI vs SLD →
ACL Full Analysis → MYX Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).